Rio Times
Brazil’s Eurofarma Teams With Japan’s Eisai to Bring the Insomnia Drug Dayvigo to Market
Eurofarma has partnered with Japan's Eisai to sell the insomnia drug lemborexant (Dayvigo) in Brazil, targeting a market worth about US$240 million a year. The post Brazil’s Eurofarma Teams With Japan’s Eisai to Bring the Insomnia Drug…
View original source — Rio Times ↗
Related stories
TASS
BusinessAug 17, 2026 · 1 min
SPIEF allows for more meetings than usually held in six months — official
TASS
The Punch
BusinessAug 17, 2026 · 1 min
No victor, no vanquished, Accord chair calls for unity after Osun election
The Punch
TASS
BusinessAug 17, 2026 · 1 min
Google registers four trademarks in Russia, including AlphaEvolve, service logos
TASS
The New York Times
BusinessAug 17, 2026 · 1 min
‘Buy Now, Pay Later’ Lenders Pitch Loans for Needs Like Electricity and Rent
The New York Times